home / stock / ctso / ctso news


CTSO News and Press, CytoSorbents Corporation From 11/13/25

Stock Information

Company Name: CytoSorbents Corporation
Stock Symbol: CTSO
Market: NASDAQ
Website: cytosorbents.com

Menu

Get CTSO Alerts

News, Short Squeeze, Breakout and More Instantly...

CTSO - Here are the major earnings after the close Thursday

2025-11-13 10:00:00 ET Read the full article on Seeking Alpha For further details see: Here are the major earnings after the close Thursday

CTSO - Expected US Company Earnings on Thursday, November 13th, 2025

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

CTSO - CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire PRINCETON, N.J. , Nov. 11, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and...

CTSO - CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire PRINCETON, N.J. , Oct. 30, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care u...

CTSO - In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer PR Newswire PRINCETON, N.J. , Oct. 28, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the tre...

CTSO - CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen PR Newswire PRINCETON, N.J. , Sept. 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment...

CTSO - CytoSorbents Provides DrugSorb-ATR Regulatory Update

CytoSorbents Provides DrugSorb-ATR Regulatory Update PR Newswire PRINCETON, N.J. , Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac sur...

CTSO - CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day PR Newswire PRINCETON, N.J. , Sept. 8, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a l...

CTSO - CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire PRINCETON, N.J. , Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the i...

CTSO - Cytosorbents outlines DrugSorb ATR regulatory appeals and targets core business breakeven as German reorganization drives 22% sales growth

2025-08-08 13:23:38 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call Transcript Cytosorbents Corporation (CTSO) Q1 2025 Earnings Call Transcript Cytosorbents outlines plans for DrugSorb-ATR appeal and targets breakeven core business by se...

Previous 10 Next 10